Profil
James E.
Pitts is currently the Director at Abeome Corp.
since 2009.
Prior to this, he worked as a Principal at Randcor, Inc.
Postes actifs de James E. Pitts
| Sociétés | Poste | Début |
|---|---|---|
Abeome Corp.
 Abeome Corp. BiotechnologyHealth Technology Abeome Corp. operates as a biotechnology company. It develops therapeutic and diagnostic monoclonal antibodies (mAbs). The firm’s DiSH (Direct Selection of Hybridomas) technology offers a process for selecting and cloning desired hybridomas that produce antibodies with optimal binding characteristics. The company was founded by Richard B. Meagher in 2000 and is headquartered in Athens, GA. | Directeur/Membre du Conseil | 18/11/2009 |
Anciens postes connus de James E. Pitts
| Sociétés | Poste | Fin |
|---|---|---|
| Randcor, Inc. | Corporate Officer/Principal | - |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 2 |
|---|---|
Abeome Corp.
Abeome Corp. BiotechnologyHealth Technology Abeome Corp. operates as a biotechnology company. It develops therapeutic and diagnostic monoclonal antibodies (mAbs). The firm’s DiSH (Direct Selection of Hybridomas) technology offers a process for selecting and cloning desired hybridomas that produce antibodies with optimal binding characteristics. The company was founded by Richard B. Meagher in 2000 and is headquartered in Athens, GA. | Health Technology |
| Randcor, Inc. |
